Target intelligence / Profile preview

T cell receptor beta variable 7-9 domain (TRBV7-9)

Target
TRBV7-9
Molecular classification
Receptor, Immunoglobulin superfamily, Variable domain
01

Overview

T cell receptor beta variable 7-9 domain (TRBV7-9) is the variable region of the beta chain of the T cell receptor (TCR) that participates in the recognition of antigens presented by the major histocompatibility complex (MHC) on antigen-presenting cells[4][6]. The variable domains (V) of TCRs are responsible for antigen specificity and are located at the N-terminus of the receptor[3]. Antigen recognition by these domains is essential for adaptive immune responses. The TRBV7-9 sequence is one of many possible Vβ gene segments used in generating the diversity of the TCR repertoire[4][6]. The TRBV7-9 domain itself is not directly a therapeutic target, enzyme, transporter, or other typical druggable entity, but is a genetic/structural component of the TCR complex. Thus, it is not considered a therapeutic target on its own. Notes on correctness: "T cell receptor β variable 7-9 domain" refers to a specific genetic segment used to generate variable regions in TCR molecules, rather than a standalone or conventional drug target protein. There is nothing intrinsically wrong with the name, but it is not commonly considered a therapeutic target as an isolated entity; rather, it is a molecular part of the TCR beta chain and functions only within the larger TCR complex[4][6].

Other names
TCR beta variable 7-9TRBV7-9
02

Biological functions

Antigen recognitionImmune response
03

Disease associations

Cancer (through antigen-specific T cell responses)Infection (role in T cell-mediated immunity)Other (in any disease involving the adaptive immune system)

Beyond the preview

Go deeper on T cell receptor beta variable 7-9 domain (TRBV7-9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor beta variable 7-9 domain (TRBV7-9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call